Etoricoxib 90 mg

DRUG4 trials

Sponsors

Organon and Co, Clinica Virgen Milagrosa, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Conditions

Arthritis, RheumatoidAxial SpondyloarthritisPain, PostoperativeSoft Tissue Injuries of the ShoulderTenosynovitis and Bursitis Affecting the Shoulder

Phase 3

Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)

CompletedNCT00820027

Organon and CoPain, Postoperative

Start: 2008-12-15End: 2010-12-14Updated: 2022-02-09

Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder

TerminatedNCT00876317

Clinica Virgen MilagrosaSoft Tissue Injuries of the Shoulder, Tenosynovitis and Bursitis Affecting the Shoulder

Start: 2009-11-30End: 2010-12-31Updated: 2012-07-03

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

CompletedNCT01208181

Organon and CoArthritis, Rheumatoid

Start: 2010-09-27End: 2014-07-29Updated: 2024-06-18

Phase 4

Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients

CompletedNCT03582332

Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshAxial Spondyloarthritis

Start: 2016-01-02End: 2016-06-23Updated: 2018-07-11

Related Papers

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial

BMC Musculoskeletal Disorders2016-08-0825 citations

Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.

2013-10-2423 citations